Pipeline
EM Imaging portfolio
Edinburgh Molecular Imaging has a portfolio of agents designed to improve detection and treatment of Cancer. All Agents progressed to date have been found to be safe, specific, sensitive and selective.
Therapy
Indications to be disclosed at a later stage.
PET Imaging
Optical Imaging
EMI-137 (Optical Agent) was previously known as GE-137. See related publications here.